Skip to main content
SpringerLink
Log in

Hodgkin-Lymphom bei Kindern und Jugendlichen

von Schweinitz

  • Chapter
  • First Online:
Kinderchirurgie

Part of the book series: Springer Reference Medizin ((SRM))

  • 5272 Accesses

Zusammenfassung

Das Hodgkin-Lymphom im Kindes- und Jugendalter gehört zu den Krebserkrankungen mit den höchsten Heilungsraten. Bei einem Langzeitüberleben von >90 % ist die Verringerung der Spätfolgen im Bereich der Fertilität, der kardiovaskulären Erkrankungen und der Sekundärmalignome Ziel kooperativer internationaler Studien. Mit einer risikoadaptierten, responsebasierten Therapiestrategie kann heute bei der Mehrzahl der Patienten auf eine Radiotherapie verzichtet werden. Patienten mit Rezidiv oder refraktärer Erkrankung haben mit einer autologen und/oder allogenen Stammzelltransplantation eine hohe Wahrscheinlichkeit eine Remission zu erreichen. Vom klassischen Hodgkin-Lymphom wird das noduläre Lymphozyten-prädominante Hodgkin-Lymphom abgegrenzt und eigenen Therapiekonzepten zugeführt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 369.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Ansell SM, Lesokhin AM, Borrello I, Hawani A, Scott EC, Gutierrez M, Schuster SJ, Millenson MM, Cattry D, Freeman GJ, Rodig SJ, Chapuy B, Ligon AH, Zhu K, Grosso JF, Kim SY, Timmerman JM, Shipp MA (2015) Armand PPD-1 blockade with nivolumab in relapsed or refractory Hodgkin’s lymphoma. N Engl J Med 372:311–319

    Article  Google Scholar 

  • Armand P, Shipp MA, Ribrag V, Michot JM, Zinzani PL, Kuruvilla J, Snyder ES, Ricart AD, Balakumaran A, Rose S, Moskowitz CH(2016) Programmed death-1 blockade with pembrolizumab in patients with classical Hodgkin lymphoma after brentuximab vedotin failure. J Clin Oncol .pii: JCO673467. [Epub vor Druck]

    Google Scholar 

  • Caporaso NE, Goldin LR, Anderson WF, Landgren O (2009) Current insight on trends, causes, and mechanisms of Hodgkin’s lymphoma. Cancer J 15:117–123

    Article  Google Scholar 

  • Devillier R, Coso D, Castagna L, Brenot Rossi I, Anastasia A, Chiti A, Ivanov V, Schiano JM, Santoro A, Chabannon C, Balzarotti M, Blaise D, Bouabdallah R (2012) Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin’s lymphoma responding to prior salvage therapy. Haematologica 97:1073–1079

    Article  Google Scholar 

  • Dinand V, Dawar R, Arya LS, Unni R, Mohanty B, Singh R (2007) Hodgkin’s lymphoma in Indian children: prevalence and significance of Epstein-Barr virus detection in Hodgkin’s and Reed-Sternberg cells. Eur J Cancer 43(1):161–168

    Article  Google Scholar 

  • Fan Z, Natkunam Y, Bair E, Tibshirani R, Warnke RA (2003) Characterization of variant patterns of nodular lymphocyte predominant Hodgkin Lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol 27:1346–1356

    Article  Google Scholar 

  • Gorde-Grosjean S, Oberlin O, Leblanc T, Pacquement H, Donadieu J, Lambilliotte A, Schell M, Dommange F, Munzer M, Paillard C, Schmitt C, Lutz P, Edan C, Ansoborlo S, Stephan JL, Michel G, Thomas C, Perel Y, Robert A, Landman-Parker J (2012) Outcome of children and adolescents with recurrent/refractory classical Hodgkin lymphoma, a study from the Societe Francaise de Lutte contre le Cancer des Enfants et des Adolescents (SFCE). Br J Haematol 158:649–656

    Article  Google Scholar 

  • Green MR, Monti S, Rodig SJ, Juszczynski P, Currie T, O’Donell E, Chapuy B, Takeyama K, Neuberg D, Golub TR, Kutok JL, Shipp MA (2010) Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Blood 116:3268–3277

    Article  CAS  Google Scholar 

  • Harker-Murray PD, Drachtman RA, Hodgson DC, Chauvenet AR, Kelly KM, Cole PD (2014) Stratification of treatment intensity in relapsed pediatric Hodgkin lymphoma. Pediatr Blood Cancer 61:579–586

    Article  Google Scholar 

  • Hjalgrim H, Askling J, Sorensen P, Madsen M, Rosdahl N, Storm HH, Hamilton-Dutoit S, Eriksen LS, Frisch M, Ekbom A, Melbye M (2000) Risk of Hodgkin’s disease and other cancers after infectious mononucleosis. J Natl Cancer Inst 92(18):1522–1528

    Article  CAS  Google Scholar 

  • Jaffe ES (2009) The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. ASH Educ Book 2009:523–531

    Google Scholar 

  • Klapper W, Oschlies I (2012) Specifics of histopathological and genetical diagnosis and classification of lymphomas in children and adolescents. Klin Padiatr 224:183–190

    Article  CAS  Google Scholar 

  • Küppers R (2009) Molecular biology of Hodgkin lymphoma. Hematol Am Soc Hematol Educ Program 2009:491–496

    Google Scholar 

  • Küppers R (2012) New insights in the biology of Hodgkin lymphoma. Hematol Am Soc Hematol Educ Program 2012:328–334

    Google Scholar 

  • Lieskovsky YE, Donaldson SS, Torres MA, Wong RM, Amylon RD, Link MP, Agarwal R (2004) High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric Hodgkin’s disease: results and prognostic indices. J Clin Oncol 22:4532–4540

    Article  Google Scholar 

  • Lister TA, Crowther D, Sutcliffe SB, Glatstein E, Canellos GP, Young RC, Rosenberg SA, Coltman CA, Tubiana M (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin’s disease: Cotswolds meeting. J Clin Oncol 7:1630–1636

    Article  CAS  Google Scholar 

  • Locatelli F, Mauz-Koerholz C, Neville K, Llort A, Beishuizen A, Daw S, Pillon M, Aladjidi N, Klingebiel T, Landman-Parker J, Medina-Sanson A, August K, Huebner D, Sachs Jm Hoffman K, Kinley J, Song S, Song G, Zhang S, Gore L (2017) A phase1/2 study of brentuximab vedotin in pediatric parients with relapsed/refractory (R/R) systemic anaplastic large-cell lymphoma (sALCL) or R/R Hodgkin lymphoma (HL). Hematol Oncol 35(S2):248–249

    Article  Google Scholar 

  • Mauz-Körholz C, Gorde-Grosjean S, Hasenclever D, Shankar A, Dörffel W, Wallace WH, Schellong G, Robert A, Körholz D, Oberlin O, Hall GW, Landman-Parker J (2007) Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma. Cancer 110:179–185

    Article  Google Scholar 

  • Mauz-Körholz C, Hasenclever D, Dörffel W, Ruschke K, Pelz T, Voigt A, Stiefel M, Winkler M, Vilser C, Dieckmann K, Karlén J, Bergsträsser E, Fosså A, Mann G, Hummel M, Klapper W, Stein H, Vordermark D, Kluge R, Körholz D (2010) Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin’s lymphoma: the GPOH-HD-2002 study. J Clin Oncol 28:3680–3686

    Article  Google Scholar 

  • Mauz-Körholz C, Lange T, Hasenclever D, Burkhardt B, Feller AC, Dörffel W, Kluge R, Vordermark D, Körholz D (2015a) Pediatric nodular lymphocyte-predominant Hodgkin lymphoma: treatment recommendations of the GPOH-HD study group. Klin Padiatr 227:314–321

    Article  Google Scholar 

  • Mauz-Körholz C, Metzger ML, Kelly KM, Schwartz CL, Castellanos ME, Dieckmann K, Kluge R, Körholz D (2015b) Pediatric Hodgkin Lymphoma. J Clin Oncol 33(27):2975–2985

    Article  Google Scholar 

  • Mauz-Körholz C, Ströter N, Baumann J, Botzen A, Körholz K, Körholz D (2017) Pharmacotherapeutic management of pediatric lymphoma. Pediatr Drugs; im Druck.

    Google Scholar 

  • Metzger ML, Hudson MM, Krasin MJ, Wu J, Kaste SC, Kun LE, Sandlund JT, Howard SC (2010) Initial response to salvage therapy determines prognosis in relapsed pediatric Hodgkin lymphoma patients. Cancer 116:4376–4384

    Article  Google Scholar 

  • Munker R, Stengel A, Stäbler A, Hiller E, Brehm G (1995) Diagnostic accuracy of ultrasound and computed tomography in the staging of Hodgkin’s disease. Verification by laparotomy in 100 cases. Cancer 76:1460–1466

    Article  CAS  Google Scholar 

  • Nogova L, Reineke T, Brillant C, Sieniawski M, Rudiger T, Josting A, Bredenfeld H, Skripnitchenko R, Muller RP, Muller-Hermelink HK, Diehl V, Engert A, German Hodgkin Study Group (2008) Lymphocyte-predominant and classical Hodgkin’s lymphoma: a comprehensive analysis from the German Hodgkin Study Group. J Clin Oncol 26:434–439

    Article  Google Scholar 

  • Pardoll DM (2012) The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12:252–264

    Article  CAS  Google Scholar 

  • Peggs KS, Hunter A, Chopra R, Parker A, Mahendra P, Milligan D, Craddock C, Pettengell R, Dogan A, Thomson KJ, Morris EC, Hale G, Waldmann H, Goldstone AH, Linch DC, Mackinnon S (2005) Clinical evidence of a graft-versus-Hodgkin’s-lymphoma effect after reduced-intensity allogeneic transplantation. Lancet 365:1934–1941

    Article  Google Scholar 

  • Peggs KS, Kayani I, Edwards N, Kottaridis P, Goldstone AH, Linch DC, Hough R, Morris EC, Fielding A, Chakraverty R, Thomson KJ, Mackinnon S (2011) Donor lymphocyte infusions modulate relapse risk in mixed chimeras and induce durable salvage in relapsed patients after T-cell-depleted allogeneic transplantation for Hodgkin’s lymphoma. J Clin Oncol 29:971–978

    Article  CAS  Google Scholar 

  • Pellegrino B, Terrier-Lacombe MJ, Oberlin O, Leblanc T, Perel Y, Bertrand Y, Beard C, Edan C, Schmitt C, Plantaz D, Pacquement H, Vannier JP, Lambilliote C, Couillault G, Babin-Boilletot A, Thuret I, Demeocq F, Leverger G, Delsol G, Landman-Parker J, Study of the French Society of Pediatric Oncology (2003) Lymphocyte-predominant Hodgkin’s lymphoma in children: therapeutic abstention after initial lymph node resection – a Study of the French Society of Pediatric Oncology. J Clin Oncol 21:2948–2952

    Article  CAS  Google Scholar 

  • Purz S, Mauz-Körholz C, Körholz D, Hasenclever D, Krausse A, Sorge I, Ruschke K, Stiefel M, Amthauer H, Schober O, Kranert WT, Weber WA, Haberkorn U, Hundsdörfer P, Ehlert K, Becker M, Rössler J, Kulozik AE, Sabri O, Kluge R (2011) [18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin’s lymphoma. J Clin Oncol 29:3523–3528

    Article  Google Scholar 

  • Roemer MG, Advani RH, Ligon AH, Natkunam Y, Redd RA, Homer H, Connelly CF, Sun HH, Daadi SE, Freeman GJ, Armand P, Chapuy B, de Jong D, Hoppe RT, Neubeg DS, Rodig SJ, Shipp MA (2016) PD-L1 and PD-L2 genetic alterations define classical Hodgkin lymphoma and predict outcome. J Clin Oncol 34:2690–2697

    Article  CAS  Google Scholar 

  • Satwani P, Ahn KW, Carreras J, Abdel-Azim H, Cairo MS, Cashen A, Chen AI, Cohen JB, Costa LJ, Dandoy C, Fenske TS, Freytes CO, Ganguly S, Gale RP, Ghosh N, Hertzberg MS, Hayashi RJ, Kamble RT, Kanate AS, Keating A, Kharfan-Dabaja MA, Lazarus HM, Marks DI, Nishihori T, Olsson RF, Prestidge TD, Rolon JM, Savani BN, Vose JM, Wood WA, Inwards DJ, Bachanova V, Smith SM, Maloney DG, Sureda A, Hamadani M (2015) A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphoma. Bone Marrow Transplant 50(11):1416–1423

    Article  CAS  Google Scholar 

  • Schellong G, Dörffel W, Claviez A, Körholz D, Mann G, Scheel-Walter HG, Bökkerink JP, Riepenhausen M, Lüders H, Pötter R, Rühl U, DAL/GPOH (2005) Salvage therapy of progressive and recurrent Hodgkin’s disease: results from a multicenter study of the pediatric DAL/GPOH-HD study group. J Clin Oncol 23:6181–6189

    Article  Google Scholar 

  • Schmitz N, Pfistner B, Sextro M, Sieber M, Carella AM, Haenel M, Boissevain F, Zschaber R, Muller P, Kirchner H, Lohri A, Decker S, Koch B, Hasenclever D, Goldstone AH, Diehl V, German Hodgkin’s Lymphoma Study Group, Lymphoma Working Party of the European Group for Blood and Marrow Transplantation (2002) Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin’s lymphoma: a randomised trial. Lancet 359:2065–2071

    Article  CAS  Google Scholar 

  • Shankar A, Hall GW, Gorde-Grosjean S, Hasenclever D, Leblanc T, Hayward J, Lambilliotte A, Daw S, Perel Y, McCarthy K, Lejars O, Oberlin WO, Wallace WH, Landman-Parker J (2012) Treatment outcome after low intensity chemotherapy [CVP] in children and adolescents with early stage nodular lymphocyte predominant Hodgkin’s lymphoma – an Anglo-French collaborative report. Eur J Cancer 48:1700–1706

    Article  Google Scholar 

  • Sureda A, Pereira MI, Dreger P (2012) The role of hematopoietic stem cell transplantation in the treatment of relapsed/refractory Hodgkin’s lymphoma. Curr Opin Oncol 24:727–732

    Article  CAS  Google Scholar 

  • Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood Epub 2016 Mar 15

    Google Scholar 

  • Thorley-Lawson DA, Gross A (2004) Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 350:1328–1337

    Article  CAS  Google Scholar 

  • Younes A, Bartlett NL, Leonard JP, Kennedy DA, Lynch CM, Sievers EL, Forero-Torres A (2010) Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas. N Engl J Med 363:1812–1821

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abt. für Pädiatrische Hämatologie/Onkologie, Universitätsklinikum Gießen/Marburg, Gießen, Deutschland

    Christine Mauz-Körholz

  2. Klinik für Kinderchirurgie, Universitätsklinikum Gießen/Marburg, Marburg, Deutschland

    Guido Seitz

Authors
  1. Christine Mauz-Körholz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Guido Seitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christine Mauz-Körholz .

Editor information

Editors and Affiliations

  1. Kinderchirurgische Klinik und Poliklinik im Dr. von Haunerschen Kinderspital, LMU München, München, Germany

    Dietrich von Schweinitz

  2. Klinik für Kinderchirurgie, Medizinische Hochschule Hannover (MHH), Hannover, Germany

    Benno Ure

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Mauz-Körholz, C., Seitz, G. (2019). Hodgkin-Lymphom bei Kindern und Jugendlichen. In: von Schweinitz, D., Ure, B. (eds) Kinderchirurgie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-58202-2_91

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-58202-2_91

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-58201-5

  • Online ISBN: 978-3-662-58202-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation